Catalent Pharma Solutions Claimed Company
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com. read more
Catalent Pharma Solutions Director of Investor Relations Salaries in New York
$40k
$85k
$130k
$150k
$214k
$279k
N/A
Average Compensation
Director of Investor Relations Salaries at Catalent Pharma Solutions
Compensation at Catalent Pharma Solutions by Department
In New York, The Communications Department averages $36,624 more than the Enterprise Risk Department.
Communications
$207,701 Enterprise Risk
$171,077 -$37k
Product
$131,391 -$76k
How Directors of Investor Relations at Catalent Pharma Solutions Rate Their Compensation
The majority of Directors of Investor Relations at Catalent Pharma Solutions believe they're compensated fairly. 100% of Directors of Investor Relations at Catalent Pharma Solutions say they receive annual bonuses, and the vast majority (74%) are satisfied with their benefits. See more compensation ratings at Catalent Pharma Solutions
×